Literature DB >> 7679920

Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylated triantennary glycans.

Y Aoyagi1, Y Suzuki, K Igarashi, A Saitoh, M Oguro, T Yokota, S Mori, T Suda, M Isemura, H Asakura.   

Abstract

Chemical structures of the sugar chains of various human alpha-fetoprotein (AFP) species with different affinity for Concanavalin A (Con A) and Lens culinaris agglutinin (LCA) were examined by pyridylamination of their oligosaccharides and stepwise exoglycosidase digestion. Using reversed-phase and size-fractionation high performance liquid chromatography systems we identified six pyridylamino-sugar chains. The Con A-reactive and LCA-nonreactive species of AFP from patients with hepatocellular carcinoma contained a biantennary sugar chain, and the Con A-reactive and LCA-reactive species had a biantennary one with a fucose residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive and LCA-reactive species contained a biantennary sugar chain both with a bisecting-N-acetylglucosamine residue at the trimannosyl core and with a focus residue at the innermost N-acetylglucosamine residue. The Con A-nonreactive and LCA-nonreactive species contained a fucosylated triantennary sugar chain as a major component, and two minor components: a triantennary sugar chain and a biantennary sugar chain with a bisecting-N-acetylglucosamine residue at the trimannosyl core. Thus, the fucosylated and non-fucosylated triantennary sugar chains were newly identified in human AFP. Essentially identical results were obtained for AFP from the patient with gallbladder carcinoma which metastasizes to the liver. These results indicate that the increment in fucosylation and branching to form new antennae is a characteristic feature of the carbohydrate chains of AFP from patients with neoplastic diseases of the liver.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679920      PMCID: PMC1968279          DOI: 10.1038/bjc.1993.91

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  28 in total

1.  Alpha-fetoprotein in a patient with gastric carcinoma metastatic to the liver.

Authors:  E Alpert; V W Pinn; K J Isselbacher
Journal:  N Engl J Med       Date:  1971-11-04       Impact factor: 91.245

2.  Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data.

Authors:  G I Abelev
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

3.  Relation of alpha-fetoprotein in acute hepatitis to severity and prognosis.

Authors:  G G Karvountzis; A G Redeker
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The carbohydrate-binding specificity of pea and lentil lectins. Fucose is an important determinant.

Authors:  K Kornfeld; M L Reitman; R Kornfeld
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  Structure of the asparagine-linked sugar chains of alpha-fetoprotein purified from human ascites fluid.

Authors:  H Yoshima; T Mizuochi; M Ishii; A Kobata
Journal:  Cancer Res       Date:  1980-11       Impact factor: 12.701

7.  Carbohydrate structure of the concanavalin A molecular variants of alpha-fetoprotein.

Authors:  T Krusius; E Ruoslahti
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

8.  Microheterogeneity of alpha-fetoprotein in patient serum as demonstrated by lectin affino-electrophoresis.

Authors:  J Breborowicz; A Mackiewicz; D Breborowicz
Journal:  Scand J Immunol       Date:  1981-07       Impact factor: 3.487

9.  Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract.

Authors:  K R McIntire; T A Waldmann; C G Moertel; V L Go
Journal:  Cancer Res       Date:  1975-04       Impact factor: 12.701

10.  Comparative chemical structures of human alpha-fetoproteins from fetal serum and from ascites fluid of a patient with hepatoma.

Authors:  Y Aoyagi; T Ikenaka; F Ichida
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

View more
  12 in total

Review 1.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Divergent Chemoenzymatic Synthesis of Asymmetrical-Core-Fucosylated and Core-Unmodified N-Glycans.

Authors:  Tiehai Li; Min Huang; Lin Liu; Shuo Wang; Kelley W Moremen; Geert-Jan Boons
Journal:  Chemistry       Date:  2016-11-22       Impact factor: 5.236

3.  Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Nikhil Anbarasan; Lucy Betesh; Aykan Karabudak; Ethan Moritz; Karthik Devarajan; Jorge Marrero; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

4.  A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Authors:  Yannan Qin; Yaogang Zhong; Tianran Ma; Jiaxu Zhang; Ganglong Yang; Feng Guan; Zheng Li; Baozhen Li
Journal:  Glycoconj J       Date:  2017-04-08       Impact factor: 2.916

5.  The usefulness of anti-fucosylated antigen antibody YB-2 for diagnosis of hepatocellular carcinoma.

Authors:  J Nakamura; S Yazawa; T Hada; T Asao; H Naitoh; S Takenoshita; M Kosaka; S Akamatsu; T Tachikawa; Y Nagamachi
Journal:  Glycoconj J       Date:  1997-01       Impact factor: 2.916

6.  Clinical and laboratory parameters associated with li-rads as diagnostic of liver nodule in patients with cirrhosis.

Authors:  Clarissa Rocha Cruz; Ana Rita Marinho Ribeiro Carvalho; Augusto César Nascimento Maranhão; Dayse Barbosa Aroucha; Gabriela Azevedo Foinquinos; Sylene Rampche Coutinho Carvalho; Luydson Richardson Silva Vasconcelos; Leila Maria Moreira Beltrão Pereira
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

7.  'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.

Authors:  P J Johnson; N Leung; P Cheng; C Welby; W T Leung; W Y Lau; S Yu; S Ho
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 8.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

9.  Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Authors:  S Ho; P Cheng; J Yuen; A Chan; N Leung; W Yeo; T Leung; W Y Lau; A K Li; P J Johnson
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.

Authors:  López-Cortés Rubén; Muinelo-Romay Laura; Fernández-Briera Almudena; Gil Martín Emilio
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.